← Back to news
Y

Yahoo Finance

The Structural Threat AT&T Didn't See Coming

Y

Silicon Motion Stock Rockets As Sales More Than Double

Y

Galaxy Digital Leads Investment In Blockchain Startup Fence

Y

Optimism Surrounds Praxis Precision Medicines (PRAX) Amid Potential FDA Approval for Ulixacaltamide

Y

What Makes Denali Therapeutics (DNLI) One of the Best Biotech Stocks to Invest in

Y

Ultragenyx Pharmaceutical (RARE) Garnering Bullish Sentiment With Forthcoming GTX-102 Phase 3 Angelman Trial

Y

H.C. Wainwright Reaffirms Buy Rating for Legend Biotech (LEGN)

Y

Opes Wealth Sells Its Entire FIXD Stake -- Is This $9.3 Million Bond ETF Exit A Signal?

Y

Crinetics Pharmaceuticals (CRNX) is One of the Best Biotech Stocks to Buy, Here is Why

Y

Ocular Therapeutix Inc. (OCUL) Appears Highly Attractive Following SOL-1 Clinical Trial Data

Y

Here is Why Structure Therapeutics (GPCR) is One of the Top Biotech Names to Look at

Y

Fed Decision Looms, Tech Earnings Could Drive Volatile Session: Dow Jones, S&P, Nasdaq, Wall Street Futures

Y

They Built A Career In Mechanical Engineering. Now They're Stuck In The 'Overqualified Trap' And Can't Even Get Hired At A Grocery Store

Y

GE Vernova: This Brand New Energy Player Could Be the 1 Stock You'll Wish You'd Bought in 2026

Y

As Marvell Acquires Polariton, Should You Buy, Sell, or Hold MRVL Stock?

Y

Do You Believe in The Long-Term Growth Outlook of Thermo Fisher Scientific (TMO)?

Y

In A Victory, Gemini Put In Four Million GM Cars

Y

AbbVie beats Q1 2026 earnings, raises full-year forecast

Y

Ex-Mars CEO named Lipton chair

Y

Robinhood's crypto revenue tanks 47%, gap filled by prediction markets

Y

Regeneron Slumps On An Unexpected Setback For Its Bread-And-Butter Drug

Y

BMW i Ventures has a new $300M fund and AI is riding shotgun

Y

Eli Lilly and Company (LLY) Declined in Q1 Despite Strong Results

Y

Seagate Stock Soars After AI Demand Powers Big Earnings Beat

Y

Do Wall Street Analysts Like Bristol-Myers Squibb Stock?

Y

Lululemon Founder Takes Aim at New CEO Pick, Escalates Proxy Fight

Y

Treasury Yields Rise as Powell Confirms He Is Staying on Fed Board

Y

Should You Be Bullish on Natera (NTRA)?

Y

Why data storage stocks are a key AI play

Y

Federal Reserve holds interest rates steady as divisions emerge, Powell announces he'll stay on as governor

Y

Fed meeting today: Central bank 'firmly parked' on interest rate pause

Y

Teva Surges 12% — And It's Not Completely Tied To Earnings

Y

'Did I save too much?': Your 401(k) may be at all-time highs, but big balances carry hidden retirement risks

Y

Meta Stock Edges Lower With Q1 Results Due. Here Are 2 Earnings Numbers To Watch.

Y

Here’s Why Polen Focus Growth Exited Abbott Laboratories (ABT) in Q1

Y

Daily – Vickers Top Insider Picks for 04/29/2026

Y

Daily – Vickers Top Buyers & Sellers for 04/29/2026

Y

German, Spanish Inflation Reach Multiyear Highs

Y

What Makes Rollins (ROL) an Attractive Investment?

Y

Polen Focus Growth Bets on Lam Research (LRCX), a Critical Supplier of Etch and Deposition Equipment

Y

AbbVie Shakes Off The 'Negative Sentiment' That Clouded Its Big Beat

Y

Here’s What Pressured CoStar Group (CSGP) in Q1

Y

C3 Metals continues to define copper resource at Khaleesi project with latest drill results

Y

Yum China Q1 Earnings Call Highlights

Y

Veralto Q1 Earnings Call Highlights

Y

Trustmark Highlights Record 2025 Net Income at Annual Meeting as Shareholders Approve Proposals

Y

GSK Q1 Earnings Call Highlights

Y

Fannie Mae Q1 Earnings Call Highlights

Y

Symrise Q1 Earnings Call Highlights

Y

Polen Focus Growth Sold Its Stake in Boston Scientific (BSX) Over Competition Concerns

Y